N-Zyme Biomedical today announced the successful closing of its Series A financing, raising approximately US$4.6 million to accelerate the advancement of its Phase 2 clinical programs and further the ...

The ability to build resilience, not just security partnerships, may be the United States' greatest strategic advantage in ...

Traditionally, treatments focused on boosting serotonin levels or other neurotransmitters, resulting in long waiting periods for patients to notice any changes, without any assurance of effectiveness.

The 2026 World Artificial Intelligence Conference (WAIC) and High-Level Meeting on Global AI Governance opened in Shanghai on ...

A humanoid robot, wearing a safety helmet, gets fine-tuned in Shanghai on Thursday, ahead of the 2026 World AI Conference and ...

The 19th World Congress of the International Federation for Cervical Pathology and Colposcopy (IFCPC) took place in Paris, France, in 2026. Held concurrently was an international expert consensus ...

Frost & Sullivan has officially released the "Global Antibody Drug Industry Development Blue Book 2026". The Blue Book provides a systematic overview ...

Anova to manage delivery of Phase 1 study of Kromastat (formerly known as NBS-M001) for the treatment of relapsed or refractory cutaneous and peripheral T-cell lymphoma Anova to accelerate ...

The latest draft of the Comprehensive Plan contains some notable updates, like priority growth areas, but still some errors and outdated information.

Paradigm Biopharmaceuticals has drawn down Tranche 4 of its US$27 million convertible note facility with Obsidian Global Partners, securing an additional US$3 million in working capital. The funds ...

At a time when most destinations compete on scale, convenience, and comprehensive offerings, Happitat began with a different question: How can we design a place that enables lasti ...

Mumbai-based real estate developer Paradigm Realty Group has raised Rs 100 crore ($10.4 million) from Arnya RealEstates Fund ...